Dr. Greenbaum was chair of the Department of Radiology at Orlando Health and is a Past-President of the American Institute of Ultrasound in Medicine (AIUM). As president of AIUM, he led the organization’s effort to support FDA approval of a non-cardiac indication for an ultrasound contrast agent (UCA). He also was the lead author of the AIUM’s guideline for the use of an UCA in the performance of a clinical trial for liver imaging. As a radiologist who performed conventional ultrasound examinations for many years, he recognized the enormous potential of contrast enhanced ultrasound (CEUS) to improve ultrasound imaging and, therefore, patient care.
The information, references and opinions provided on this website do not constitute the offering of medical advice or create a physician-patient relationship between any one or more of (a) the International Contrast Ultrasound Society (ICUS), its directors and members, and the contributors to this website, and (b) you, your patients, and any other party. ICUS makes no express or implied warranties regarding the accuracy or completeness of the information, references and opinions on this website, and ICUS shall not be liable to you, your patients, or anyone else with respect to any medical decision made, or any action taken or not taken, in direct or indirect reliance on this information.